# Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

> **NCT03995732** · PHASE2 · UNKNOWN · sponsor: **Beijing Tide Pharmaceutical Co., Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Myocardial Reperfusion Injury

## Interventions

- **DRUG:** PC-SOD
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03995732
- **Lead sponsor:** Beijing Tide Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-18
- **Primary completion:** 2020-10-31
- **Final completion:** 2021-03-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03995732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03995732, "Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03995732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*